Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
Clinical trial NCT04386746 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04386746
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-10-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.